tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Larry Biegelsen, 406 are a BUY (65.27%), 206 are a HOLD (33.12%), 10 are a SELL (1.61%).
Analyst Larry Biegelsen, currently employed at WELLS FARGO, carries an average stock price target met ratio of 66.7% that have a potential upside of 15.2% achieved within 173 days.
Larry Biegelsen’s has documented 1,265 price targets and ratings displayed on 22 stocks. The coverage is on Healthcare, Communication Services sectors.
Most recent stock forecast was given on BSX, Boston Scientific Corp at 24-Sep-2026.
Analyst best performing recommendations are on NPCE (NEUROPACE).
The best stock recommendation documented was for NPCE (NEUROPACE) at 5/17/2021. The price target of $25 was fulfilled within 1 day with a profit of $3.28 (15.1%) receiving and performance score of 151.01.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 08-Apr-2022
$98
$34.24 (53.70%)
$98
20 days ago
(15-Sep-2026)
13/31 (41.94%)
$30.24 (44.63%)
399
Hold Since 12-Aug-2026
$78.4
$14.64 (22.96%)
$77.53
1 months 23 days ago
(12-Aug-2026)
5/7 (71.43%)
$4.82 (6.55%)
86
Buy Since 15-Apr-2019
$85
$21.24 (33.31%)
$80
1 months 23 days ago
(12-Aug-2026)
9/19 (47.37%)
$11.42 (15.52%)
413
Buy Since 17-Oct-2022
$82
$18.24 (28.61%)
$82
1 months 24 days ago
(11-Aug-2026)
12/23 (52.17%)
$6.65 (8.83%)
108
Hold Since 13-Oct-2025
$78
$10.2 (15.04%)
$90
4 months 27 days ago
(08-May-2026)
11/13 (84.62%)
$15.44 (24.68%)
557
Which stock is Larry Biegelsen most bullish on?
Which stock is Larry Biegelsen most reserved on?
What Year was the first public recommendation made by Larry Biegelsen?
